166 related articles for article (PubMed ID: 31151422)
21. Effects of apicidin, a histone deacetylase inhibitor, on the regulation of apoptosis in H-ras-transformed breast epithelial cells.
Park H; Im JY; Kim J; Choi WS; Kim HS
Int J Mol Med; 2008 Mar; 21(3):325-33. PubMed ID: 18288380
[TBL] [Abstract][Full Text] [Related]
22. Effects of metastasis-associated in colon cancer 1 inhibition by small hairpin RNA on ovarian carcinoma OVCAR-3 cells.
Zhang R; Shi H; Chen Z; Wu Q; Ren F; Huang H
J Exp Clin Cancer Res; 2011 Sep; 30(1):83. PubMed ID: 21923915
[TBL] [Abstract][Full Text] [Related]
23. RNAi‑mediated knockdown of PRL‑3 inhibits cell invasion and downregulates ERK 1/2 expression in the human gastric cancer cell line, SGC‑7901.
Cao Y; Tu Y; Mei J; Li Z; Jie Z; Xu S; Xu L; Wang S; Xiong Y
Mol Med Rep; 2013 Jun; 7(6):1805-11. PubMed ID: 23589069
[TBL] [Abstract][Full Text] [Related]
24. Ras-ERK1/2 Signaling Promotes The Development Of Osteosarcoma By Regulating H2BK12ac Through CBP.
Xu X; Yu H; Xu Y
Cancer Manag Res; 2019; 11():9153-9163. PubMed ID: 31695502
[TBL] [Abstract][Full Text] [Related]
25. Phosphorylation of H2A.X
Liu Y; Long YH; Wang SQ; Li YF; Zhang JH
FEBS J; 2016 Dec; 283(24):4462-4473. PubMed ID: 27813335
[TBL] [Abstract][Full Text] [Related]
26. Ets1 was significantly activated by ERK1/2 in mutant K-ras stably transfected human adrenocortical cells.
Chen YF; Shin SJ; Lin SR
DNA Cell Biol; 2005 Feb; 24(2):126-32. PubMed ID: 15699632
[TBL] [Abstract][Full Text] [Related]
27. Effect of KIF22 on promoting proliferation and migration of gastric cancer cells via MAPK-ERK pathways.
Yu ZY; Jiang XY; Zhao RR; Qin JJ; Luo CJ; Ren YX; Ren W; Ma ZJ; Jiao ZY
Chin Med J (Engl); 2020 Apr; 133(8):919-928. PubMed ID: 32187050
[TBL] [Abstract][Full Text] [Related]
28. Myc antagonizes Ras-mediated growth arrest in leukemia cells through the inhibition of the Ras-ERK-p21Cip1 pathway.
Vaqué JP; Navascues J; Shiio Y; Laiho M; Ajenjo N; Mauleon I; Matallanas D; Crespo P; León J
J Biol Chem; 2005 Jan; 280(2):1112-22. PubMed ID: 15528212
[TBL] [Abstract][Full Text] [Related]
29. E2F1-activated SPIN1 promotes tumor growth via a MDM2-p21-E2F1 feedback loop in gastric cancer.
Lv BB; Ma RR; Chen X; Zhang GH; Song L; Wang SX; Wang YW; Liu HT; Gao P
Mol Oncol; 2020 Oct; 14(10):2629-2645. PubMed ID: 32767629
[TBL] [Abstract][Full Text] [Related]
30. Protein kinase C alpha trigger Ras and Raf-independent MEK/ERK activation for TPA-induced growth inhibition of human hepatoma cell HepG2.
Wen-Sheng W
Cancer Lett; 2006 Jul; 239(1):27-35. PubMed ID: 16169661
[TBL] [Abstract][Full Text] [Related]
31. BLU-554, A selective inhibitor of FGFR4, exhibits anti-tumour activity against gastric cancer in vitro.
Zhang X; Zhang X; Han R; Wang Z; Yang Q; Huang Y; Yan Y
Biochem Biophys Res Commun; 2022 Mar; 595():22-27. PubMed ID: 35093636
[TBL] [Abstract][Full Text] [Related]
32. Down-regulation of Sprouty2 in non-small cell lung cancer contributes to tumor malignancy via extracellular signal-regulated kinase pathway-dependent and -independent mechanisms.
Sutterlüty H; Mayer CE; Setinek U; Attems J; Ovtcharov S; Mikula M; Mikulits W; Micksche M; Berger W
Mol Cancer Res; 2007 May; 5(5):509-20. PubMed ID: 17510316
[TBL] [Abstract][Full Text] [Related]
33. Function of RasGRP3 in the formation and progression of human breast cancer.
Nagy Z; Kovács I; Török M; Tóth D; Vereb G; Buzás K; Juhász I; Blumberg PM; Bíró T; Czifra G
Mol Cancer; 2014 Apr; 13():96. PubMed ID: 24779681
[TBL] [Abstract][Full Text] [Related]
34. ERK pathway activation contributes to the tumor-promoting effects of hepatic stellate cells in hepatocellular carcinoma.
Xie YX; Liao R; Pan L; Du CY
Immunol Lett; 2017 Aug; 188():116-123. PubMed ID: 28668554
[TBL] [Abstract][Full Text] [Related]
35. Erianin, the main active ingredient of Dendrobium chrysotoxum Lindl, inhibits precancerous lesions of gastric cancer (PLGC) through suppression of the HRAS-PI3K-AKT signaling pathway as revealed by network pharmacology and in vitro experimental verification.
Wang Y; Chu F; Lin J; Li Y; Johnson N; Zhang J; Gai C; Su Z; Cheng H; Wang L; Ding X
J Ethnopharmacol; 2021 Oct; 279():114399. PubMed ID: 34246740
[TBL] [Abstract][Full Text] [Related]
36. The protein kinase MAP3K19 phosphorylates MAP2Ks and thereby activates ERK and JNK kinases and increases viability of KRAS-mutant lung cancer cells.
Hoang VT; Nyswaner K; Torres-Ayuso P; Brognard J
J Biol Chem; 2020 Jun; 295(25):8470-8479. PubMed ID: 32358059
[TBL] [Abstract][Full Text] [Related]
37. Retracted: Ras-ERK1/2 signaling promotes the development of uveal melanoma by downregulating H3K14ac.
Li Y; Sun W; Sun D; Yin D
J Cell Physiol; 2019 Sep; 234(9):16011-16020. PubMed ID: 30770563
[TBL] [Abstract][Full Text] [Related]
38. Hepatocyte growth factor/scatter factor activates the ETS1 transcription factor by a RAS-RAF-MEK-ERK signaling pathway.
Paumelle R; Tulasne D; Kherrouche Z; Plaza S; Leroy C; Reveneau S; Vandenbunder B; Fafeur V
Oncogene; 2002 Apr; 21(15):2309-19. PubMed ID: 11948414
[TBL] [Abstract][Full Text] [Related]
39. RASSF7 promotes cell proliferation through activating MEK1/2-ERK1/2 signaling pathway in hepatocellular carcinoma.
Zhang M; Li Q; Zhang L; Wang Y; Wang L; Li Q; He T; Wan B; Wang X
Cell Mol Biol (Noisy-le-grand); 2018 Apr; 64(5):73-79. PubMed ID: 29729697
[TBL] [Abstract][Full Text] [Related]
40. Nitric oxide and cGMP activate the Ras-MAP kinase pathway-stimulating protein tyrosine phosphorylation in rabbit aortic endothelial cells.
Oliveira CJ; Schindler F; Ventura AM; Morais MS; Arai RJ; Debbas V; Stern A; Monteiro HP
Free Radic Biol Med; 2003 Aug; 35(4):381-96. PubMed ID: 12899940
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
